Healthcare Sector Stocks
The Healthcare sector has a total of 1053 stocks, with a combined market cap of $9.61 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 51.00.
Market Cap
9.61T
Revenue
4.67T
Profits
188.36B
PE Ratio
51.00
Profit Margin
4.03%
Dividend Yield
0.38%
1052 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.14T | 0.45% | 2,106,876 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 641.07B | 0.94% | 5,777,445 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 506.70B | 0.39% | 4,516,377 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 368.64B | -1.77% | 4,587,862 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 346.91B | -3.21% | 13,103,797 | 66.57B |
| 6 | NVS | Novartis AG | 292.89B | 1.78% | 2,816,388 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 266.16B | 0.33% | 3,310,152 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 253.24B | 1.64% | 1,947,836 | 47.35B |
| 9 | AMGN | Amgen Inc. | 240.38B | 1.22% | 2,053,001 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 196.77B | 1.70% | 6,047,661 | 30.46B |
| 11 | ABT | Abbott Laboratories | 181.48B | 1.14% | 7,842,175 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 172.34B | 0.20% | 8,041,531 | 50.34B |
| 13 | PFE | Pfizer Inc. | 169.79B | -0.80% | 25,656,349 | 63.70B |
| 14 | DHR | Danaher Corporation | 163.90B | 1.07% | 3,121,051 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 156.55B | -0.15% | 3,065,513 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 131.16B | -1.23% | 1,189,036 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 125.85B | 0.21% | 7,844,901 | 49.19B |
| 18 | CVS | CVS Health Corporation | 118.34B | -1.01% | 4,257,993 | 412.65B |
| 19 | SYK | Stryker Corporation | 117.42B | -0.33% | 1,894,470 | 25.84B |
| 20 | MDT | Medtronic plc | 116.04B | -0.65% | 8,464,533 | 37.54B |
| 21 | MCK | McKesson Corporation | 115.76B | -0.79% | 508,221 | 410.98B |
| 22 | GSK | GSK plc | 102.44B | 0.69% | 3,609,437 | 44.05B |
| 23 | HCA | HCA Healthcare, Inc. | 100.73B | -0.80% | 1,881,216 | 78.01B |
| 24 | SNY | Sanofi | 99.92B | 0.46% | 2,683,602 | 55.89B |
| 25 | ELV | Elevance Health, Inc. | 93.19B | -1.96% | 1,437,382 | 201.83B |
| 26 | CI | The Cigna Group | 80.80B | -0.38% | 1,785,423 | 282.38B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 80.65B | 0.33% | 423,959 | 15.53B |
| 28 | MRNA | Moderna, Inc. | 79.39B | -0.62% | 17,108,669 | 2.23B |
| 29 | BSX | Boston Scientific Corporation | 66.06B | -0.24% | 11,928,716 | 21.00B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 64.93B | 0.94% | 2,367,366 | 28.42B |
| 31 | COR | Cencora, Inc. | 62.97B | -0.30% | 993,481 | 332.77B |
| 32 | NTRA | Natera, Inc. | 58.36B | 0.24% | 1,429,672 | 2.71B |
| 33 | CAH | Cardinal Health, Inc. | 58.25B | 0.79% | 1,690,650 | 254.25B |
| 34 | ARGX | argenx SE | 54.57B | -0.50% | 269,569 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 53.49B | -1.27% | 1,640,119 | 22.48B |
| 36 | EW | Edwards Lifesciences Corporation | 52.20B | 1.67% | 3,326,977 | 6.51B |
| 37 | VEEV | Veeva Systems Inc. | 51.52B | -1.50% | 1,122,840 | 3.46B |
| 38 | HUM | Humana Inc. | 50.10B | -1.15% | 1,303,658 | 145.68B |
| 39 | A | Agilent Technologies, Inc. | 49.61B | 1.67% | 1,709,765 | 7.37B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 46.55B | 1.37% | 6,032,430 | 17.32B |
| 41 | IQV | IQVIA Holdings Inc. | 45.03B | -2.06% | 1,689,265 | 16.98B |
| 42 | IDXX | IDEXX Laboratories, Inc. | 44.92B | 1.75% | 528,164 | 4.55B |
| 43 | WAT | Waters Corporation | 44.80B | 0.51% | 909,151 | 4.64B |
| 44 | HLN | Haleon plc | 44.71B | -0.68% | 15,270,636 | 14.80B |
| 45 | MDLN | Medline Inc. | 44.29B | -1.17% | 8,132,394 | 29.94B |
| 46 | ONC | BeOne Medicines AG | 42.17B | -1.79% | 354,606 | 6.13B |
| 47 | ILMN | Illumina, Inc. | 40.93B | 0.60% | 1,329,654 | 4.49B |
| 48 | RVMD | Revolution Medicines, Inc. | 39.42B | -1.65% | 1,660,256 | - |
| 49 | BIIB | Biogen Inc. | 37.27B | 0.63% | 958,847 | 10.03B |
| 50 | RPRX | Royalty Pharma plc | 37.24B | 1.41% | 4,108,090 | 2.54B |
| 51 | RMD | ResMed Inc. | 35.61B | 0.13% | 1,074,678 | 5.65B |
| 52 | ALC | Alcon Inc. | 33.87B | -0.26% | 1,463,453 | 10.86B |
| 53 | CNC | Centene Corporation | 33.61B | -3.05% | 6,514,882 | 180.30B |
| 54 | ZTS | Zoetis Inc. | 33.46B | -0.07% | 2,903,944 | 9.53B |
| 55 | MTD | Mettler-Toledo International Inc. | 33.45B | -0.04% | 128,766 | 4.13B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 32.51B | 0.74% | 2,868,639 | 21.27B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.46B | 1.62% | 1,436,999 | 4.80B |
| 58 | DXCM | DexCom, Inc. | 29.65B | 0.81% | 6,026,319 | 4.97B |
| 59 | WST | West Pharmaceutical Services, Inc. | 27.78B | 0.66% | 649,659 | 3.33B |
| 60 | LH | Labcorp Holdings Inc. | 26.75B | 0.29% | 653,776 | 14.35B |
| 61 | DGX | Quest Diagnostics Incorporated | 26.73B | 0.44% | 959,622 | 11.84B |
| 62 | GMAB | Genmab A/S | 26.50B | 2.04% | 7,473,718 | 4.13B |
| 63 | PHG | Koninklijke Philips N.V. | 26.17B | -1.19% | 2,041,911 | 20.18B |
| 64 | ROIV | Roivant Sciences Ltd. | 26.04B | -1.21% | 9,868,965 | 7.53M |
| 65 | UTHR | United Therapeutics Corporation | 25.43B | 0.91% | 577,007 | 3.15B |
| 66 | GH | Guardant Health, Inc. | 23.25B | 2.47% | 1,997,001 | 1.18B |
| 67 | INCY | Incyte Corporation | 22.97B | -2.07% | 2,264,061 | 5.82B |
| 68 | STE | STERIS plc | 22.44B | -0.87% | 805,443 | 6.04B |
| 69 | BNTX | BioNTech SE | 21.82B | -1.43% | 1,406,945 | 3.03B |
| 70 | THC | Tenet Healthcare Corporation | 21.66B | 0.19% | 645,678 | 21.81B |
| 71 | VTRS | Viatris Inc. | 21.01B | 1.61% | 6,060,515 | 14.74B |
| 72 | INSM | Insmed Incorporated | 20.38B | -0.06% | 3,379,925 | 1.14B |
| 73 | MEDP | Medpace Holdings, Inc. | 18.93B | 1.13% | 306,535 | 2.84B |
| 74 | ZBH | Zimmer Biomet Holdings, Inc. | 18.59B | -1.14% | 2,682,242 | 8.51B |
| 75 | RVTY | Revvity, Inc. | 17.90B | 1.02% | 1,089,209 | 2.91B |
| 76 | CRL | Charles River Laboratories International, Inc. | 17.06B | 3.45% | 1,176,005 | 4.00B |
| 77 | EXEL | Exelixis, Inc. | 16.13B | 0.90% | 1,674,632 | 2.44B |
| 78 | ASND | Ascendis Pharma A/S | 16.10B | 0.73% | 545,416 | 1.20B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 14.83B | 2.22% | 1,285,053 | 3.37B |
| 80 | SOLV | Solventum Corporation | 14.61B | 0.47% | 975,574 | 8.31B |
| 81 | HALO | Halozyme Therapeutics, Inc. | 14.53B | 1.89% | 1,237,637 | 1.66B |
| 82 | ICLR | ICON Public Limited Company | 14.18B | -0.80% | 1,066,446 | 8.29B |
| 83 | JAZZ | Jazz Pharmaceuticals plc | 13.35B | -3.88% | 970,044 | 4.60B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.32B | -0.60% | 2,059,136 | 713.07M |
| 85 | BAX | Baxter International Inc. | 13.07B | -0.04% | 4,043,456 | 11.47B |
| 86 | PEN | Penumbra, Inc. | 12.81B | 0.26% | 434,164 | 1.50B |
| 87 | SNN | Smith & Nephew plc | 12.70B | -1.17% | 1,296,227 | 6.30B |
| 88 | BTSG | BrightSpring Health Services, Inc. | 12.27B | -2.05% | 1,945,320 | 14.37B |
| 89 | EHC | Encompass Health Corporation | 12.24B | 0.01% | 843,864 | 6.21B |
| 90 | TEM | Tempus AI, Inc. | 12.12B | -0.67% | 3,775,016 | 1.43B |
| 91 | FMS | Fresenius Medical Care AG | 12.08B | 0.31% | 569,774 | 22.19B |
| 92 | DVA | DaVita Inc. | 11.74B | 0.21% | 570,374 | 14.01B |
| 93 | AVTR | Avantor, Inc. | 11.69B | - | 6,743,176 | 6.56B |
| 94 | COO | The Cooper Companies, Inc. | 11.63B | -0.11% | 1,834,702 | 4.24B |
| 95 | SMMT | Summit Therapeutics Inc. | 11.60B | -6.27% | 4,782,986 | - |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.47B | 1.95% | 4,205,515 | 5.02B |
| 97 | RDY | Dr. Reddy's Laboratories Limited | 11.41B | 4.09% | 4,121,884 | 3.44B |
| 98 | TECH | Bio-Techne Corporation | 11.40B | 0.19% | 2,798,432 | 1.22B |
| 99 | GMED | Globus Medical, Inc. | 10.99B | 0.52% | 1,031,160 | 3.14B |
| 100 | UHS | Universal Health Services, Inc. | 10.95B | -0.63% | 721,004 | 18.11B |
| 101 | ALGN | Align Technology, Inc. | 10.82B | -1.46% | 942,204 | 4.14B |
| 102 | BMRN | BioMarin Pharmaceutical Inc. | 10.79B | -0.36% | 2,360,995 | 3.41B |
| 103 | MOH | Molina Healthcare, Inc. | 10.67B | -2.08% | 871,427 | 42.08B |
| 104 | GKOS | Glaukos Corporation | 10.51B | -0.34% | 1,067,474 | 612.84M |
| 105 | QGEN | Qiagen N.V. | 10.42B | -0.04% | 4,113,081 | 2.10B |
| 106 | PODD | Insulet Corporation | 10.35B | 0.17% | 1,525,635 | 3.05B |
| 107 | ENSG | The Ensign Group, Inc. | 10.22B | 0.76% | 490,009 | 5.49B |
| 108 | RGEN | Repligen Corporation | 10.17B | 1.83% | 1,177,804 | 785.10M |
| 109 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.11B | 0.81% | 275,872 | 1.28B |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 9.96B | 0.67% | 179,101 | 2.59B |
| 111 | OSCR | Oscar Health, Inc. | 9.59B | 0.35% | 4,944,161 | 15.32B |
| 112 | KYMR | Kymera Therapeutics, Inc. | 9.55B | 3.68% | 438,576 | 105.00M |
| 113 | TXG | 10x Genomics, Inc. | 9.51B | 1.97% | 1,413,121 | 616.91M |
| 114 | PCVX | Vaxcyte, Inc. | 9.44B | -0.76% | 1,469,429 | - |
| 115 | HSIC | Henry Schein, Inc. | 9.42B | -0.53% | 937,893 | 13.60B |
| 116 | CORT | Corcept Therapeutics Incorporated | 9.42B | 1.47% | 1,872,205 | 830.81M |
| 117 | KRYS | Krystal Biotech, Inc. | 9.28B | 0.69% | 223,645 | 440.48M |
| 118 | CAI | Caris Life Sciences, Inc. | 9.17B | 1.42% | 1,999,106 | 989.61M |
| 119 | TWST | Twist Bioscience Corporation | 9.11B | 3.81% | 1,379,528 | 431.80M |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 9.08B | 1.37% | 823,278 | 281.99M |
| 121 | HNGE | Hinge Health, Inc. | 9.01B | 0.17% | 2,076,067 | 720.06M |
| 122 | BRKR | Bruker Corporation | 8.87B | 1.11% | 2,333,462 | 3.50B |
| 123 | SYRE | Spyre Therapeutics, Inc. | 8.68B | 2.86% | 637,181 | - |
| 124 | HQY | HealthEquity, Inc. | 8.58B | -0.21% | 909,463 | 1.36B |
| 125 | CYTK | Cytokinetics, Incorporated | 8.44B | -0.82% | 783,239 | 67.67M |
| 126 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.33B | 1.65% | 979,892 | 669.50M |
| 127 | IBRX | ImmunityBio, Inc. | 8.28B | -4.99% | 11,049,308 | 165.79M |
| 128 | ATR | AptarGroup, Inc. | 8.08B | 0.41% | 370,664 | 3.93B |
| 129 | TGTX | TG Therapeutics, Inc. | 7.77B | 1.14% | 1,187,449 | 799.54M |
| 130 | PACS | PACS Group, Inc. | 7.72B | 2.35% | 1,093,310 | 5.55B |
| 131 | ABVX | ABIVAX Société Anonyme | 7.60B | -1.72% | 423,694 | 5.33M |
| 132 | AXSM | Axsome Therapeutics, Inc. | 7.55B | -0.68% | 886,185 | 776.57M |
| 133 | PRAX | Praxis Precision Medicines, Inc. | 7.47B | 5.70% | 389,761 | 7.46M |
| 134 | ALKS | Alkermes plc | 7.46B | 1.86% | 1,176,642 | 1.67B |
| 135 | AMRX | Amneal Pharmaceuticals, Inc. | 7.32B | 3.14% | 4,945,331 | 3.12B |
| 136 | IONS | Ionis Pharmaceuticals, Inc. | 7.22B | 1.14% | 3,197,537 | 874.09M |
| 137 | GRFS | Grifols, S.A. | 7.13B | 4.76% | 845,888 | 8.48B |
| 138 | CHE | Chemed Corporation | 6.68B | -0.02% | 127,665 | 2.60B |
| 139 | LNTH | Lantheus Holdings, Inc. | 6.52B | 0.12% | 431,648 | 1.56B |
| 140 | HIMS | Hims & Hers Health, Inc. | 6.44B | -0.43% | 5,755,607 | 2.58B |
| 141 | BLCO | Bausch + Lomb Corporation | 6.28B | 0.63% | 499,276 | 5.32B |
| 142 | GRAL | GRAIL, Inc. | 6.25B | 5.55% | 891,370 | 165.26M |
| 143 | IOVA | Iovance Biotherapeutics, Inc. | 6.24B | -2.20% | 7,442,623 | 324.97M |
| 144 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.16B | 0.22% | 289,450 | 239.92M |
| 145 | LGND | Ligand Pharmaceuticals Incorporated | 6.15B | 1.57% | 194,782 | 290.54M |
| 146 | ORKA | Oruka Therapeutics, Inc. | 5.98B | 12.70% | 1,942,847 | - |
| 147 | DOCS | Doximity, Inc. | 5.90B | -0.93% | 2,246,409 | 655.57M |
| 148 | IMVT | Immunovant, Inc. | 5.82B | -0.84% | 1,195,303 | - |
| 149 | TFX | Teleflex Incorporated | 5.80B | 0.37% | 683,011 | 2.25B |
| 150 | BLTE | Belite Bio, Inc | 5.77B | -2.70% | 137,152 | - |
| 151 | MANE | Veradermics, Incorporated | 5.74B | -1.00% | 392,750 | - |
| 152 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.69B | -4.89% | 1,434,042 | 840.85M |
| 153 | MMSI | Merit Medical Systems, Inc. | 5.62B | 0.96% | 1,001,068 | 1.58B |
| 154 | KOD | Kodiak Sciences Inc. | 5.62B | 2.25% | 927,029 | - |
| 155 | RDNT | RadNet, Inc. | 5.51B | -0.41% | 340,095 | 2.27B |
| 156 | WAY | Waystar Holding Corp. | 5.50B | -0.55% | 1,388,424 | 1.21B |
| 157 | CGON | CG Oncology, Inc. | 5.46B | -0.24% | 880,160 | 6.23M |
| 158 | STVN | Stevanato Group S.p.A. | 5.43B | 2.00% | 182,975 | 1.40B |
| 159 | HAE | Haemonetics Corporation | 5.42B | 0.57% | 469,738 | 1.35B |
| 160 | MIRM | Mirum Pharmaceuticals, Inc. | 5.41B | 3.58% | 429,984 | 618.07M |
| 161 | COGT | Cogent Biosciences, Inc. | 5.37B | -0.96% | 2,205,992 | - |
| 162 | BLLN | BillionToOne, Inc. | 5.26B | 3.43% | 404,781 | 397.41M |
| 163 | MMED | MiniMed Group, Inc. | 5.25B | 1.74% | 5,289,814 | 3.22B |
| 164 | SHC | Sotera Health Company | 5.25B | 1.60% | 2,047,910 | 1.22B |
| 165 | ERAS | Erasca, Inc. | 5.24B | 4.17% | 6,466,123 | - |
| 166 | CON | Concentra Group Holdings Parent, Inc. | 5.13B | 2.42% | 1,759,722 | 2.29B |
| 167 | PTCT | PTC Therapeutics, Inc. | 5.10B | 0.79% | 708,776 | 1.01B |
| 168 | SRRK | Scholar Rock Holding Corporation | 5.08B | 0.53% | 1,678,241 | - |
| 169 | LFST | LifeStance Health Group, Inc. | 4.99B | 1.01% | 3,524,589 | 1.58B |
| 170 | HTFL | HeartFlow, Inc. | 4.96B | 0.52% | 1,058,739 | 212.07M |
| 171 | DFTX | Definium Therapeutics, Inc. | 4.79B | 0.03% | 1,054,043 | - |
| 172 | CRSP | CRISPR Therapeutics AG | 4.74B | -0.77% | 1,066,928 | 13.39M |
| 173 | TVTX | Travere Therapeutics, Inc. | 4.71B | -0.22% | 3,341,603 | 591.33M |
| 174 | OPCH | Option Care Health, Inc. | 4.68B | 0.03% | 2,046,108 | 5.69B |
| 175 | LIVN | LivaNova PLC | 4.44B | -0.35% | 362,376 | 1.47B |
| 176 | DNTH | Dianthus Therapeutics, Inc. | 4.44B | 3.32% | 501,183 | 1.90M |
| 177 | ITGR | Integer Holdings Corporation | 4.30B | -0.02% | 827,840 | 1.84B |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 4.25B | -0.36% | 1,018,069 | - |
| 179 | ADPT | Adaptive Biotechnologies Corporation | 4.19B | 2.98% | 1,164,557 | 308.08M |
| 180 | ICUI | ICU Medical, Inc. | 4.15B | -0.40% | 155,385 | 2.16B |
| 181 | INDV | Indivior Pharmaceuticals, Inc. | 4.08B | 0.26% | 916,793 | 1.33B |
| 182 | IRTC | iRhythm Holdings, Inc. | 4.02B | 0.54% | 434,851 | 825.34M |
| 183 | ARQT | Arcutis Biotherapeutics, Inc. | 4.00B | 1.96% | 1,547,906 | 463.98M |
| 184 | RLAY | Relay Therapeutics, Inc. | 3.97B | -0.33% | 1,585,748 | 10.35M |
| 185 | LEGN | Legend Biotech Corporation | 3.95B | 5.81% | 2,369,678 | 1.27B |
| 186 | LQDA | Liquidia Corporation | 3.92B | 2.56% | 4,116,397 | 450.91M |
| 187 | ABCL | AbCellera Biologics Inc. | 3.91B | 2.20% | 3,038,418 | 66.17M |
| 188 | VCYT | Veracyte, Inc. | 3.87B | 0.56% | 748,111 | 561.90M |
| 189 | NVST | Envista Holdings Corporation | 3.80B | 0.25% | 3,153,611 | 2.86B |
| 190 | PLSE | Pulse Biosciences, Inc. | 3.76B | -0.68% | 282,617 | 1.19M |
| 191 | TNGX | Tango Therapeutics, Inc. | 3.74B | -4.91% | 5,370,564 | 53.81M |
| 192 | OGN | Organon & Co. | 3.61B | -0.07% | 1,548,459 | 6.13B |
| 193 | CDNA | CareDx, Inc. | 3.57B | -0.16% | 602,954 | 458.09M |
| 194 | NHC | National HealthCare Corporation | 3.50B | -5.22% | 245,440 | 1.56B |
| 195 | XENE | Xenon Pharmaceuticals Inc. | 3.46B | 1.22% | 726,714 | 7.50M |
| 196 | IRON | Disc Medicine, Inc. | 3.45B | 4.23% | 1,222,038 | - |
| 197 | ACAD | Acadia Pharmaceuticals Inc. | 3.40B | 0.05% | 1,229,734 | 1.14B |
| 198 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.40B | -0.40% | 1,371,106 | -665.00K |
| 199 | RGC | Regencell Bioscience Holdings Limited | 3.35B | -11.86% | 450,561 | - |
| 200 | CELC | Celcuity Inc. | 3.22B | 0.84% | 1,866,289 | - |
| 201 | IDYA | IDEAYA Biosciences, Inc. | 3.17B | -5.27% | 1,188,206 | 234.13M |
| 202 | WRBY | Warby Parker Inc. | 3.12B | -2.43% | 2,142,402 | 911.61M |
| 203 | ATRC | AtriCure, Inc. | 3.11B | 3.58% | 816,229 | 569.62M |
| 204 | PBLS | Parabilis Medicines, Inc. | 3.09B | 2.41% | 1,427,695 | 148.00K |
| 205 | TARS | Tarsus Pharmaceuticals, Inc. | 3.07B | 2.68% | 877,126 | 606.33M |
| 206 | TLX | Telix Pharmaceuticals Limited | 3.05B | -1.75% | 323,417 | 890.79M |
| 207 | ELVN | Enliven Therapeutics, Inc. | 3.04B | -0.07% | 2,323,118 | - |
| 208 | SGRY | Surgery Partners, Inc. | 3.02B | 47.62% | 58,820,828 | 3.37B |
| 209 | DNLI | Denali Therapeutics Inc. | 2.98B | 1.36% | 726,046 | 3.60M |
| 210 | DYN | Dyne Therapeutics, Inc. | 2.94B | 0.64% | 1,741,944 | - |
| 211 | ACHC | Acadia Healthcare Company, Inc. | 2.92B | -0.54% | 1,370,142 | 3.37B |
| 212 | AVAH | Aveanna Healthcare Holdings Inc. | 2.88B | -1.49% | 1,831,278 | 2.60B |
| 213 | PRVA | Privia Health Group, Inc. | 2.83B | -1.12% | 840,556 | 2.36B |
| 214 | VKTX | Viking Therapeutics, Inc. | 2.82B | -0.78% | 3,564,093 | - |
| 215 | NRIX | Nurix Therapeutics, Inc. | 2.79B | 0.83% | 2,336,966 | 701.94M |
| 216 | ZLAB | Zai Lab Limited | 2.73B | 1.29% | 1,739,128 | 449.61M |
| 217 | NEOG | Neogen Corporation | 2.67B | 0.16% | 1,692,014 | 884.00M |
| 218 | VRDN | Viridian Therapeutics, Inc. | 2.64B | 4.34% | 1,515,418 | 71.13M |
| 219 | RCUS | Arcus Biosciences, Inc. | 2.52B | -4.21% | 2,699,612 | 117.00M |
| 220 | GRDN | Guardian Pharmacy Services, Inc. | 2.48B | -0.63% | 212,146 | 1.46B |
| 221 | ADMA | ADMA Biologics, Inc. | 2.48B | 3.60% | 2,027,274 | 512.28M |
| 222 | TMDX | TransMedics Group, Inc. | 2.45B | -0.16% | 847,928 | 668.47M |
| 223 | HCM | HUTCHMED (China) Limited | 2.44B | -0.63% | 19,139 | 549.12M |
| 224 | CLOV | Clover Health Investments, Corp. | 2.42B | -0.87% | 2,493,628 | 2.48B |
| 225 | MBX | MBX Biosciences, Inc. | 2.42B | 3.69% | 653,050 | - |
| 226 | BEAM | Beam Therapeutics Inc. | 2.38B | -1.08% | 1,401,452 | 156.04M |
| 227 | BHC | Bausch Health Companies Inc. | 2.37B | -1.40% | 2,401,570 | 10.85B |
| 228 | SUPN | Supernus Pharmaceuticals, Inc. | 2.37B | 0.17% | 930,903 | 830.44M |
| 229 | NAMS | NewAmsterdam Pharma Company N.V. | 2.33B | -0.91% | 1,564,211 | 7.12M |
| 230 | BKD | Brookdale Senior Living Inc. | 2.33B | -3.17% | 4,988,015 | 2.93B |
| 231 | CLDX | Celldex Therapeutics, Inc. | 2.32B | 0.85% | 593,368 | 158.00K |
| 232 | MD | Pediatrix Medical Group, Inc. | 2.30B | -0.85% | 670,921 | 1.95B |
| 233 | SLS | SELLAS Life Sciences Group, Inc. | 2.29B | -1.73% | 3,214,377 | - |
| 234 | PBH | Prestige Consumer Healthcare Inc. | 2.28B | 0.73% | 588,239 | 1.10B |
| 235 | RXRX | Recursion Pharmaceuticals, Inc. | 2.27B | 2.70% | 16,104,057 | 54.86M |
| 236 | AUPH | Aurinia Pharmaceuticals Inc. | 2.27B | 1.07% | 794,704 | 311.51M |
| 237 | FTRE | Fortrea Holdings Inc. | 2.27B | 0.85% | 1,040,110 | 2.68B |
| 238 | UFPT | UFP Technologies, Inc. | 2.26B | -1.52% | 82,216 | 631.64M |
| 239 | AXGN | Axogen, Inc. | 2.23B | -0.11% | 1,021,725 | 251.17M |
| 240 | ADUS | Addus HomeCare Corporation | 2.22B | -0.53% | 202,750 | 1.48B |
| 241 | PHVS | Pharvaris N.V. | 2.21B | 0.41% | 347,676 | - |
| 242 | VCEL | Vericel Corporation | 2.20B | 1.20% | 634,753 | 306.30M |
| 243 | AGIO | Agios Pharmaceuticals, Inc. | 2.20B | -0.41% | 838,544 | 98.34M |
| 244 | PRGO | Perrigo Company plc | 2.20B | -0.88% | 1,495,215 | 4.14B |
| 245 | BHVN | Biohaven Ltd. | 2.18B | 4.11% | 2,677,188 | - |
| 246 | XNCR | Xencor, Inc. | 2.17B | 15.89% | 8,902,707 | 104.97M |
| 247 | PGEN | Precigen, Inc. | 2.16B | -2.42% | 2,547,297 | 85.72M |
| 248 | PGNY | Progyny, Inc. | 2.16B | -2.90% | 650,929 | 1.31B |
| 249 | HRMY | Harmony Biosciences Holdings, Inc. | 2.14B | 1.94% | 852,697 | 959.90M |
| 250 | NEO | NeoGenomics, Inc. | 2.14B | 0.60% | 1,302,439 | 766.30M |
| 251 | ALMR | Alamar Biosciences, Inc. | 2.11B | -0.98% | 634,331 | 100.42M |
| 252 | TRLV | Trulieve Cannabis Corp. | 2.08B | 3.84% | 1,013,162 | 1.14B |
| 253 | INSP | Inspire Medical Systems, Inc. | 2.05B | -0.14% | 528,468 | 898.74M |
| 254 | VERA | Vera Therapeutics, Inc. | 2.04B | 1.11% | 1,170,807 | - |
| 255 | IMNM | Immunome, Inc. | 2.03B | -0.56% | 910,529 | 4.02M |
| 256 | LKFT | Lakefront Biotherapeutics NV | 2.02B | 0.11% | 191,351 | 1.13B |
| 257 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.01B | 3.01% | 4,380,509 | 940.61M |
| 258 | ZYME | Zymeworks Inc. | 2.01B | 0.53% | 833,942 | 37.13M |
| 259 | ADRX | ADARx Pharmaceuticals, Inc. | 2.00B | 1.02% | 99,579 | 6.13M |
| 260 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.97B | 3.55% | 1,285,235 | 208.78M |
| 261 | ESTA | Establishment Labs Holdings Inc. | 1.96B | 3.10% | 577,999 | 245.82M |
| 262 | SEPN | Septerna, Inc. | 1.93B | 2.40% | 279,435 | 98.88M |
| 263 | LMAT | LeMaitre Vascular, Inc. | 1.93B | -0.17% | 270,609 | 262.43M |
| 264 | ASTH | Astrana Health, Inc. | 1.91B | -0.59% | 250,155 | 3.84B |
| 265 | SRPT | Sarepta Therapeutics, Inc. | 1.90B | 1.41% | 1,361,777 | 1.97B |
| 266 | AMN | AMN Healthcare Services, Inc. | 1.90B | 2.06% | 1,055,030 | 3.43B |
| 267 | VIR | Vir Biotechnology, Inc. | 1.87B | 4.45% | 1,587,362 | 303.23M |
| 268 | XERS | Xeris Biopharma Holdings, Inc. | 1.86B | 0.10% | 1,905,052 | 335.41M |
| 269 | XRAY | DENTSPLY SIRONA Inc. | 1.84B | -2.23% | 3,524,178 | 3.64B |
| 270 | SDGR | Schrödinger, Inc. | 1.83B | 2.94% | 1,264,305 | 259.04M |
| 271 | WGS | GeneDx Holdings Corp. | 1.83B | 9.10% | 1,003,961 | 454.43M |
| 272 | PVLA | Palvella Therapeutics, Inc. | 1.82B | 0.90% | 110,516 | - |
| 273 | MLYS | Mineralys Therapeutics, Inc. | 1.82B | 0.05% | 795,986 | - |
| 274 | BRVE | Braveheart Bio, Inc. | 1.79B | 2.01% | 101,221 | - |
| 275 | TRVI | Trevi Therapeutics, Inc. | 1.78B | -0.79% | 979,098 | - |
| 276 | ZBIO | Zenas BioPharma, Inc. | 1.78B | 1.38% | 371,648 | 1.00M |
| 277 | BFLY | Butterfly Network, Inc. | 1.77B | -1.48% | 3,506,315 | 112.14M |
| 278 | KMTS | Kestra Medical Technologies, Ltd. | 1.75B | 2.29% | 294,075 | 106.73M |
| 279 | MAZE | Maze Therapeutics, Inc. | 1.73B | 0.19% | 429,417 | 20.00M |
| 280 | ARDT | Ardent Health, Inc. | 1.72B | -0.73% | 237,154 | 6.41B |
| 281 | PSNL | Personalis, Inc. | 1.70B | 0.19% | 1,140,590 | 69.67M |
| 282 | HCSG | Healthcare Services Group, Inc. | 1.69B | -0.71% | 938,891 | 1.88B |
| 283 | MESO | Mesoblast Limited | 1.69B | 0.90% | 107,349 | 120.25M |
| 284 | OMCL | Omnicell, Inc. | 1.69B | -2.07% | 539,740 | 1.25B |
| 285 | ATEC | Alphatec Holdings, Inc. | 1.68B | -1.89% | 3,160,647 | 815.05M |
| 286 | COAG | Hemab Therapeutics Holdings, Inc. | 1.68B | 4.71% | 269,193 | - |
| 287 | NVCR | NovoCure Limited | 1.68B | -1.91% | 1,166,274 | 699.19M |
| 288 | URGN | UroGen Pharma Ltd. | 1.66B | -1.30% | 670,047 | 188.73M |
| 289 | KLRA | Kailera Therapeutics, Inc. | 1.66B | -0.62% | 589,399 | - |
| 290 | ALVO | Alvotech | 1.65B | 0.87% | 584,890 | 494.61M |
| 291 | STOK | Stoke Therapeutics, Inc. | 1.64B | 1.68% | 2,083,447 | 27.59M |
| 292 | ALHC | Alignment Healthcare, Inc. | 1.64B | -2.11% | 5,684,810 | 4.58B |
| 293 | AZTA | Azenta, Inc. | 1.63B | 1.84% | 657,939 | 613.81M |
| 294 | ABSI | Absci Corporation | 1.62B | 2.94% | 3,374,102 | 1.56M |
| 295 | CERT | Certara, Inc. | 1.62B | 2.71% | 2,348,222 | 421.75M |
| 296 | IMCR | Immunocore Holdings plc | 1.61B | 0.97% | 197,930 | 430.78M |
| 297 | NBTX | Nanobiotix S.A. | 1.60B | 7.39% | 129,727 | 13.15M |
| 298 | SNDA | Sonida Senior Living, Inc. | 1.59B | -0.83% | 271,749 | 481.07M |
| 299 | LYCA | Lycia Therapeutics, Inc. | 1.59B | -3.83% | 965,723 | 4.44M |
| 300 | GENB | Generate Biomedicines, Inc. | 1.59B | -0.48% | 340,898 | 26.48M |
| 301 | PAHC | Phibro Animal Health Corporation | 1.58B | 0.59% | 144,646 | 1.52B |
| 302 | NUVB | Nuvation Bio Inc. | 1.58B | -1.31% | 3,663,247 | 169.90M |
| 303 | RARE | Ultragenyx Pharmaceutical Inc. | 1.58B | 2.75% | 3,023,155 | 717.00M |
| 304 | NTLA | Intellia Therapeutics, Inc. | 1.58B | 0.45% | 2,064,597 | 59.51M |
| 305 | ANIP | ANI Pharmaceuticals, Inc. | 1.56B | -0.01% | 229,291 | 978.38M |
| 306 | TRAX | First Tracks Biotherapeutics, Inc. | 1.55B | -1.29% | 592,297 | - |
| 307 | NVAX | Novavax, Inc. | 1.55B | -3.09% | 4,941,085 | 413.80M |
| 308 | CMPS | COMPASS Pathways plc | 1.53B | -1.16% | 1,520,360 | - |
| 309 | INVA | Innoviva, Inc. | 1.52B | 1.89% | 569,096 | 440.00M |
| 310 | AGL | agilon health, inc. | 1.52B | 0.70% | 175,938 | 5.92B |
| 311 | GPCR | Structure Therapeutics Inc. | 1.50B | -0.42% | 688,970 | - |
| 312 | QURE | uniQure N.V. | 1.50B | -3.48% | 988,701 | 18.67M |
| 313 | PNTG | The Pennant Group, Inc. | 1.49B | 1.65% | 400,723 | 1.10B |
| 314 | KRSA | Korsana Biosciences, Inc. | 1.46B | 2.49% | 230,503 | - |
| 315 | ANAB | AnaptysBio, Inc. | 1.46B | 0.08% | 417,197 | 106.09M |
| 316 | PCRX | Pacira BioSciences, Inc. | 1.45B | -0.11% | 607,300 | 746.16M |
| 317 | ETON | Eton Pharmaceuticals, Inc. | 1.43B | 0.34% | 405,284 | 105.60M |
| 318 | NUTX | Nutex Health Inc. | 1.43B | -0.28% | 197,256 | 846.72M |
| 319 | CNMD | CONMED Corporation | 1.43B | -3.19% | 386,605 | 1.37B |
| 320 | OCUL | Ocular Therapeutix, Inc. | 1.42B | -0.46% | 1,690,501 | 52.06M |
| 321 | AAPG | Ascentage Pharma Group International | 1.41B | 0.06% | 3,075 | 94.61M |
| 322 | TYRA | Tyra Biosciences, Inc. | 1.40B | -0.15% | 790,340 | - |
| 323 | FRNM | Freenome, Inc. | 1.37B | -0.39% | 371,469 | 35.41M |
| 324 | USPH | U.S. Physical Therapy, Inc. | 1.32B | 0.14% | 76,194 | 804.27M |
| 325 | GHRS | GH Research PLC | 1.32B | 6.14% | 306,079 | - |
| 326 | TNDM | Tandem Diabetes Care, Inc. | 1.32B | 8.43% | 4,488,328 | 1.04B |
| 327 | DMRA | Damora Therapeutics, Inc. | 1.31B | 0.81% | 641,720 | - |
| 328 | TSHA | Taysha Gene Therapies, Inc. | 1.31B | 1.26% | 1,819,776 | 5.49M |
| 329 | INBX | Inhibrx Biosciences, Inc. | 1.30B | -5.11% | 251,184 | 1.30M |
| 330 | NKTR | Nektar Therapeutics | 1.28B | 0.62% | 532,603 | 54.59M |
| 331 | LBRX | LB Pharmaceuticals Inc | 1.27B | 1.58% | 275,975 | - |
| 332 | INNV | InnovAge Holding Corp. | 1.26B | -2.93% | 271,391 | 989.71M |
| 333 | BVS | Bioventus Inc. | 1.24B | -1.60% | 428,527 | 581.85M |
| 334 | CRON | Cronos Group Inc. | 1.22B | -1.19% | 827,875 | 179.09M |
| 335 | ENOV | Enovis Corporation | 1.22B | 0.38% | 905,914 | 2.30B |
| 336 | OPK | OPKO Health, Inc. | 1.22B | - | 1,916,913 | 587.90M |
| 337 | RAPP | Rapport Therapeutics, Inc. | 1.22B | -2.31% | 1,041,211 | 20.00M |
| 338 | VSTM | Verastem, Inc. | 1.22B | -0.40% | 4,289,252 | 87.53M |
| 339 | GDRX | GoodRx Holdings, Inc. | 1.21B | 0.56% | 892,062 | 785.23M |
| 340 | AVLN | Avalyn Pharma Inc. | 1.20B | 4.22% | 411,771 | - |
| 341 | SLN | Silence Therapeutics plc | 1.19B | 0.56% | 4,654,225 | 615.00K |
| 342 | DRTS | Alpha Tau Medical Ltd. | 1.19B | -2.05% | 379,083 | - |
| 343 | KARD | Kardigan, Inc. | 1.18B | -1.33% | 216,098 | - |
| 344 | SNDX | Syndax Pharmaceuticals, Inc. | 1.18B | -1.34% | 1,991,189 | 252.25M |
| 345 | OMER | Omeros Corporation | 1.18B | -1.69% | 741,394 | 38.42M |
| 346 | OMDA | Omada Health, Inc. | 1.18B | 1.53% | 870,441 | 309.76M |
| 347 | REPL | Replimune Group, Inc. | 1.17B | 8.81% | 2,045,760 | - |
| 348 | STAA | STAAR Surgical Company | 1.16B | 2.74% | 748,914 | 339.59M |
| 349 | SVRA | Savara Inc. | 1.15B | 7.11% | 3,449,003 | - |
| 350 | PRCT | PROCEPT BioRobotics Corporation | 1.14B | -0.65% | 701,731 | 337.34M |
| 351 | TDOC | Teladoc Health, Inc. | 1.13B | -1.58% | 3,398,206 | 2.49B |
| 352 | LMRI | Lumexa Imaging Holdings, Inc. | 1.13B | 0.69% | 309,927 | 1.04B |
| 353 | AORT | Artivion, Inc. | 1.12B | -1.37% | 366,025 | 471.47M |
| 354 | BCAX | Bicara Therapeutics Inc. | 1.12B | -1.05% | 1,051,906 | - |
| 355 | SPTX | Seaport Therapeutics, Inc. | 1.12B | 1.07% | 124,687 | - |
| 356 | AHG | Akso Health Group | 1.09B | -2.31% | 6,418 | 13.83M |
| 357 | HROW | Harrow, Inc. | 1.09B | 1.79% | 499,149 | 275.59M |
| 358 | VOR | Vor Biopharma Inc. | 1.08B | 0.38% | 470,344 | - |
| 359 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.08B | 1.31% | 225,243 | 730.02M |
| 360 | IRMD | IRADIMED CORPORATION | 1.08B | -1.39% | 182,484 | 86.34M |
| 361 | BBNX | Beta Bionics, Inc. | 1.08B | 7.05% | 1,630,975 | 119.01M |
| 362 | HSTM | HealthStream, Inc. | 1.07B | -0.85% | 155,038 | 321.12M |
| 363 | MNKD | MannKind Corporation | 1.04B | 1.25% | 1,976,552 | 393.63M |
| 364 | CBLL | CeriBell, Inc. | 1.04B | -0.37% | 311,604 | 101.96M |
| 365 | CTY | City Therapeutics, Inc. | 1.03B | 0.10% | 136,061 | 14.34M |
| 366 | JANX | Janux Therapeutics, Inc. | 1.02B | 0.18% | 379,225 | 24.00M |
| 367 | CSTL | Castle Biosciences, Inc. | 1.02B | 0.67% | 235,842 | 357.28M |
| 368 | LTGO | Latigo Biotherapeutics, Inc. | 1.01B | 1.60% | 165,324 | - |
| 369 | MLTX | MoonLake Immunotherapeutics | 1.01B | -0.34% | 1,514,732 | - |
| 370 | SGP | SpyGlass Pharma, Inc. | 1.00B | 5.02% | 89,404 | - |
| 371 | IMTX | Immatics N.V. | 977.33M | -2.19% | 756,093 | 47.65M |
| 372 | SIBN | SI-BONE, Inc. | 955.08M | -0.79% | 361,061 | 213.60M |
| 373 | QDEL | QuidelOrtho Corporation | 944.28M | 0.29% | 2,179,559 | 2.67B |
| 374 | IART | Integra LifeSciences Holdings Corporation | 941.39M | 1.60% | 916,428 | 1.66B |
| 375 | CGEM | Cullinan Therapeutics, Inc. | 935.72M | 1.18% | 438,575 | - |
| 376 | RIGL | Rigel Pharmaceuticals, Inc. | 932.31M | 3.70% | 196,564 | 276.79M |
| 377 | ORIC | ORIC Pharmaceuticals, Inc. | 928.21M | -32.00% | 6,952,474 | - |
| 378 | ODTX | Odyssey Therapeutics, Inc. | 924.83M | -1.53% | 139,919 | 99.00K |
| 379 | JBIO | Jade Biosciences, Inc. | 922.16M | -0.62% | 477,456 | - |
| 380 | GLUE | Monte Rosa Therapeutics, Inc. | 894.08M | -3.32% | 1,227,112 | 28.73M |
| 381 | IVA | Inventiva S.A. | 891.80M | -1.35% | 3,332,166 | 2.81M |
| 382 | MGTX | MeiraGTx Holdings plc | 881.67M | -0.33% | 649,158 | 397.50M |
| 383 | CRVS | Corvus Pharmaceuticals, Inc. | 879.06M | -0.76% | 981,131 | - |
| 384 | AKTS | Aktis Oncology, Inc. | 874.89M | - | 149,999 | 10.06M |
| 385 | ANRO | Alto Neuroscience, Inc. | 867.64M | 0.64% | 550,065 | - |
| 386 | OBX | Obsidian Therapeutics, Inc. | 856.17M | -0.86% | 204,801 | - |
| 387 | KURA | Kura Oncology, Inc. | 855.80M | 0.10% | 865,013 | 77.23M |
| 388 | ALMS | Alumis Inc. | 842.62M | -3.98% | 1,119,974 | 7.40M |
| 389 | GMRS | GMR Solutions Inc. | 840.17M | 0.75% | 370,461 | 5.88B |
| 390 | PHAR | Pharming Group N.V. | 834.27M | 6.25% | 43,472 | 386.75M |
| 391 | ABUS | Arbutus Biopharma Corporation | 830.96M | - | 1,405,376 | 181.72M |
| 392 | AHCO | AdaptHealth Corp. | 791.12M | -1.50% | 1,746,588 | 3.36B |
| 393 | APMD | Apnimed, Inc. | 788.90M | -0.21% | 178,554 | 115.12M |
| 394 | INMD | InMode Ltd. | 788.64M | -1.79% | 671,583 | 374.63M |
| 395 | PHR | Phreesia, Inc. | 782.71M | -0.71% | 574,954 | 507.79M |
| 396 | VREX | Varex Imaging Corporation | 775.94M | -0.05% | 758,417 | 865.00M |
| 397 | CTKB | Cytek Biosciences, Inc. | 765.60M | 5.37% | 1,240,086 | 206.71M |
| 398 | AVBP | ArriVent BioPharma, Inc. | 757.37M | -26.86% | 5,947,635 | - |
| 399 | HELP | Helus Pharma Inc. | 756.90M | 1.67% | 1,033,739 | - |
| 400 | COLL | Collegium Pharmaceutical, Inc. | 755.62M | 1.09% | 518,254 | 808.21M |
| 401 | ARDX | Ardelyx, Inc. | 747.56M | -2.60% | 5,000,625 | 450.89M |
| 402 | GERN | Geron Corporation | 738.84M | 2.68% | 11,089,634 | 204.56M |
| 403 | SANA | Sana Biotechnology, Inc. | 706.49M | 1.29% | 1,509,345 | - |
| 404 | ANNX | Annexon, Inc. | 701.44M | -1.33% | 2,648,827 | - |
| 405 | SLBT | SL Science Holding Limited | 701.43M | 6.96% | 52,457 | 3.27M |
| 406 | PACB | Pacific Biosciences of California, Inc. | 699.37M | 6.64% | 9,572,726 | 159.27M |
| 407 | IAM | Iambic Therapeutics, Inc. | 683.05M | 1.05% | 149,160 | 18.25M |
| 408 | ANL | Adlai Nortye Group Ltd. | 681.33M | - | 132,936 | 18.06M |
| 409 | SGMT | Sagimet Biosciences Inc. | 677.89M | -0.21% | 767,188 | - |
| 410 | DNA | Ginkgo Bioworks Holdings, Inc. | 674.75M | 0.30% | 1,270,147 | 132.42M |
| 411 | ACHV | Achieve Life Sciences, Inc. | 672.98M | 0.77% | 701,512 | - |
| 412 | OABI | OmniAb, Inc. | 670.25M | -1.07% | 971,630 | 38.46M |
| 413 | IMMX | Immix Biopharma, Inc. | 668.20M | -1.10% | 1,116,379 | - |
| 414 | DSGN | Design Therapeutics, Inc. | 647.09M | 0.98% | 316,692 | - |
| 415 | LXRX | Lexicon Pharmaceuticals, Inc. | 645.19M | 2.11% | 2,205,901 | 41.47M |
| 416 | GYRE | Gyre Therapeutics, Inc. | 643.62M | 3.76% | 93,375 | 109.82M |
| 417 | PRME | Prime Medicine, Inc. | 642.23M | -1.63% | 2,511,564 | 4.07M |
| 418 | STLN | Starling Oncology, Inc. | 641.05M | -6.26% | 1,866,248 | 587.24M |
| 419 | AURA | Aura Biosciences, Inc. | 640.90M | -1.90% | 907,586 | - |
| 420 | SOPH | SOPHiA GENETICS SA | 640.16M | 2.31% | 261,142 | 86.17M |
| 421 | ATTO | Attovia Therapeutics, Inc. | 633.64M | 0.36% | 224,637 | 1.80M |
| 422 | WVE | Wave Life Sciences, Inc. | 632.52M | 0.94% | 3,224,224 | 65.37M |
| 423 | KIDS | OrthoPediatrics Corp. | 627.16M | -1.96% | 378,065 | 252.72M |
| 424 | SLDB | Solid Biosciences Inc. | 622.98M | -1.86% | 1,070,935 | - |
| 425 | CRMD | CorMedix Inc. | 618.88M | 1.15% | 1,130,294 | 462.25M |
| 426 | FDMT | 4D Molecular Therapeutics, Inc. | 609.34M | 2.13% | 1,084,579 | 92.01M |
| 427 | NVCT | Nuvectis Pharma, Inc. | 602.43M | -7.78% | 318,836 | - |
| 428 | CADL | Candel Therapeutics, Inc. | 596.08M | -2.99% | 849,302 | - |
| 429 | DBVT | DBV Technologies S.A. | 593.02M | 2.36% | 214,829 | 5.04M |
| 430 | OLMA | Olema Pharmaceuticals, Inc. | 579.23M | 3.28% | 1,987,373 | - |
| 431 | IRWD | Ironwood Pharmaceuticals, Inc. | 578.34M | 1.16% | 1,131,286 | 389.32M |
| 432 | MYGN | Myriad Genetics, Inc. | 575.81M | 3.44% | 1,486,643 | 806.60M |
| 433 | ZVRA | Zevra Therapeutics, Inc. | 565.93M | -2.85% | 722,197 | 136.07M |
| 434 | AVR | Anteris Technologies Global Corp. | 563.51M | -1.53% | 739,307 | 2.24M |
| 435 | MDXG | MiMedx Group, Inc. | 561.18M | -1.53% | 1,109,256 | 355.17M |
| 436 | PBYI | Puma Biotechnology, Inc. | 560.08M | -1.54% | 355,705 | 231.24M |
| 437 | ACRS | Aclaris Therapeutics, Inc. | 557.88M | 1.07% | 1,572,733 | 8.22M |
| 438 | EVO | Evotec SE | 556.98M | 1.33% | 121,494 | 819.47M |
| 439 | FLGT | Fulgent Genetics, Inc. | 556.36M | 0.60% | 191,243 | 323.93M |
| 440 | STTK | Shattuck Labs, Inc. | 556.01M | 0.91% | 706,098 | 1.00M |
| 441 | CBIO | Crescent Biopharma, Inc. | 546.14M | -0.47% | 210,637 | 11.88M |
| 442 | TCMD | Tactile Systems Technology, Inc. | 529.84M | -1.06% | 162,482 | 350.31M |
| 443 | ETRA | Electra Therapeutics, Inc. | 525.36M | -3.90% | 159,130 | - |
| 444 | BLSM | BlossomHill Therapeutics, Inc. | 520.95M | 12.03% | 204,368 | - |
| 445 | VALN | Valneva SE | 513.03M | 2.85% | 21,301 | 163.30M |
| 446 | DRUG | Bright Minds Biosciences Inc. | 513.00M | -2.65% | 89,060 | - |
| 447 | INDP | Indaptus Therapeutics, Inc. | 512.96M | 5.70% | 352,844 | - |
| 448 | EVH | Evolent Health, Inc. | 512.16M | -5.62% | 1,730,532 | 2.10B |
| 449 | ANGO | AngioDynamics, Inc. | 511.80M | -1.62% | 458,832 | 325.38M |
| 450 | CLYM | Climb Bio, Inc. | 506.01M | -13.54% | 3,381,239 | - |
| 451 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 452 | DCTH | Delcath Systems, Inc. | 503.48M | 0.62% | 232,857 | 95.42M |
| 453 | AQST | Aquestive Therapeutics, Inc. | 498.28M | -0.75% | 1,273,418 | 54.09M |
| 454 | ENTX | Entera Bio Ltd. | 497.42M | -2.05% | 232,467 | 42.00K |
| 455 | SGHT | Sight Sciences, Inc. | 496.89M | 0.33% | 267,955 | 83.38M |
| 456 | NRC | NRC Health | 496.58M | 2.37% | 93,895 | 140.00M |
| 457 | OCS | Oculis Holding AG | 491.39M | 0.76% | 206,966 | 1.45M |
| 458 | CTMX | CytomX Therapeutics, Inc. | 484.83M | -4.09% | 5,224,019 | 18.30M |
| 459 | MASS | 908 Devices Inc. | 481.54M | 1.39% | 284,048 | 60.84M |
| 460 | ARVN | Arvinas, Inc. | 477.97M | 0.14% | 724,862 | 316.70M |
| 461 | CERS | Cerus Corporation | 477.61M | 1.72% | 982,314 | 221.55M |
| 462 | SRZN | Surrozen, Inc. | 477.27M | 7.06% | 511,217 | 11.51M |
| 463 | SSII | SS Innovations International, Inc. | 474.91M | 5.33% | 98,492 | 52.40M |
| 464 | EOLS | Evolus, Inc. | 473.58M | 2.28% | 430,113 | 316.49M |
| 465 | MNPR | Monopar Therapeutics Inc. | 473.48M | -0.16% | 84,703 | - |
| 466 | PHAT | Phathom Pharmaceuticals, Inc. | 471.81M | 3.48% | 2,113,849 | 239.66M |
| 467 | DMAC | DiaMedica Therapeutics Inc. | 471.31M | 0.23% | 129,605 | - |
| 468 | NGNE | Neurogene Inc. | 471.07M | -0.04% | 123,203 | 925.00K |
| 469 | RCEL | AVITA Medical, Inc. | 469.47M | -2.13% | 323,851 | 75.63M |
| 470 | BWAY | BrainsWay Ltd. | 451.36M | -0.36% | 75,062 | 60.70M |
| 471 | KMDA | Kamada Ltd. | 450.43M | 2.19% | 70,468 | 191.85M |
| 472 | EPRX | Eupraxia Pharmaceuticals Inc. | 448.96M | -0.29% | 540,288 | - |
| 473 | NPCE | NeuroPace, Inc. | 445.87M | 0.62% | 67,338 | 106.99M |
| 474 | FTH | Faeth Therapeutics, Inc. | 434.89M | -1.46% | 424,470 | - |
| 475 | RGNX | REGENXBIO Inc. | 434.37M | -1.50% | 1,138,425 | 174.48M |
| 476 | PRTA | Prothena Corporation plc | 431.23M | 2.44% | 594,545 | 54.53M |
| 477 | MPLT | MapLight Therapeutics, Inc. | 425.71M | -3.89% | 252,612 | - |
| 478 | AGMB | AgomAb Therapeutics NV | 422.06M | -5.30% | 73,851 | - |
| 479 | SRTA | Strata Critical Medical, Inc. | 421.10M | 2.15% | 460,507 | 255.98M |
| 480 | OVID | Ovid Therapeutics Inc. | 420.87M | -0.23% | 844,073 | 1.58M |
| 481 | ALLO | Allogene Therapeutics, Inc. | 418.04M | -3.20% | 10,576,386 | 4.64M |
| 482 | PROK | ProKidney Corp. | 411.16M | -3.55% | 761,676 | 818.00K |
| 483 | AUTL | Autolus Therapeutics plc | 407.23M | -0.65% | 1,237,587 | 117.39M |
| 484 | CARL | Carlsmed, Inc. | 407.08M | 2.62% | 123,738 | 63.30M |
| 485 | TKNO | Alpha Teknova, Inc. | 406.62M | 2.65% | 678,305 | 43.70M |
| 486 | SI | Shoulder Innovations, Inc. | 403.47M | -1.42% | 71,596 | 60.06M |
| 487 | RZLT | Rezolute, Inc. | 400.71M | -0.91% | 1,543,501 | - |
| 488 | ASMB | Assembly Biosciences, Inc. | 400.49M | -0.86% | 152,227 | 74.85M |
| 489 | TLRY | Tilray Brands, Inc. | 398.92M | -3.20% | 3,406,699 | 963.10M |
| 490 | ALT | Altimmune, Inc. | 398.76M | -3.30% | 3,498,573 | 31.00K |
| 491 | CYH | Community Health Systems, Inc. | 398.45M | 0.68% | 1,170,651 | 11.98B |
| 492 | OFIX | Orthofix Medical Inc. | 398.36M | -0.31% | 200,599 | 833.19M |
| 493 | SENS | Senseonics Holdings, Inc. | 395.50M | -0.40% | 489,403 | 48.55M |
| 494 | TECX | Tectonic Therapeutic, Inc. | 390.01M | -0.60% | 151,223 | - |
| 495 | SPRY | ARS Pharmaceuticals, Inc. | 389.83M | -2.73% | 1,433,831 | 116.93M |
| 496 | EMBC | Embecta Corp. | 385.29M | 1.34% | 679,490 | 1.02B |
| 497 | PRLD | Prelude Therapeutics Incorporated | 381.08M | 1.93% | 236,859 | 22.42M |
| 498 | YDES | YD Bio Limited | 374.70M | 6.87% | 59,784 | 1.24M |
| 499 | TRXB | TRex Bio, Inc. | 373.41M | 0.43% | 54,977 | - |
| 500 | VMD | Viemed Healthcare, Inc. | 370.60M | -0.71% | 156,978 | 301.61M |